שווי כולל של החברה: BioNexus Gene Lab Corp. (BGLC)

The price trend for BioNexus Gene Lab Corp. (BGLC) on the GURU.Markets platform based on the Enterprise Value metric is 0.08. The growth in value of BioNexus Gene Lab Corp. (BGLC) is driven by the expansion of biochemical sales in Southeast Asia and the launch of diagnostic systems. Business protection is ensured by RNA analysis patents and strict laboratory licensing in Malaysia. The company's leadership is solidified by its unique ability to identify eleven types of oncology through a single blood draw.

The strategic expansion of BioNexus Gene Lab Corp. (BGLC) through M&A and partnerships within Asia's chemical sector makes enterprise value modeling a key valuation tool. This indicator determines the total cost of the business by combining market capitalization with net debt. The formula sums the equity value and liabilities, subtracting available cash. This allows an investor to see the real acquisition price of the asset. The trend of this metric reflects the integration efficiency of new laboratories.